Breaking News, Collaborations & Alliances

Lonza, Synpromics Enter Biomanufacturing Partnership

Chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Synpromics and Lonza Pharma & Biotech have formed a partnership for the commercialization of a number of inducible promoters to improve the manufacturing of biopharmaceuticals. The commercial agreement with Lonza follows the award of an Innovate UK grant to Synpromics announced on April 23, 2018. Lonza and Synpromics worked together to develop and test these innovative promoters in Lonza’s GS Xceed Expression System.   The inducible promoters will be used by Lonza to enable efficient produ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters